Literature DB >> 2413206

Role of radiotherapy in the management of bone metastases from breast cancer.

J R Yarnold.   

Abstract

Entities:  

Mesh：

Year:  1985        PMID： 2413206      PMCID： PMC1289530     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  9 in total

1.  Single-dose irradiation of bone metastases.

Authors:  N H Jensen; K Roesdahl
Journal:  Acta Radiol Ther Phys Biol       Date:  1976-08

2.  Single-dose radiation therapy in the palliation of metastatic disease.

Authors:  Z O Vargha; A S Glicksman; J Boland
Journal:  Radiology       Date:  1969-11       Impact factor: 11.105

3.  The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group.

Authors:  D Tong; L Gillick; F R Hendrickson
Journal:  Cancer       Date:  1982-09-01       Impact factor: 6.860

4.  Single dose and fractionated palliative irradiation for osseous metastases.

Authors:  C R Penn
Journal:  Clin Radiol       Date:  1976-07       Impact factor: 2.350

5.  Radiation therapy for osseous metastasis.

Authors:  F R Hendrickson; W M Shehata; A B Kirchner
Journal:  Int J Radiat Oncol Biol Phys       Date:  1976 Jan-Feb       Impact factor: 7.038

6.  Single dose palliative irradiation for bony metastasis.

Authors:  M M Qasim
Journal:  Strahlentherapie       Date:  1977-08

7.  The effectiveness of radiation therapy in the treatment of bone metastases from breast cancer.

Authors:  C J Garmatis; F C Chu
Journal:  Radiology       Date:  1978-01       Impact factor: 11.105

8.  Effective bone palliation as related to various treatment regimens.

Authors:  K L Allen; T W Johnson; G G Hibbs
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

9.  Evaluation of radiation therapy for bone metastases: pain relief and quality of life.

Authors:  H A Gilbert; A R Kagan; H Nussbaum; A R Rao; J Satzman; P Chan; B Allen; A Forsythe
Journal:  AJR Am J Roentgenol       Date:  1977-12       Impact factor: 3.959
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.